MarketResearchReports.Biz adds “Global Genomic Vision (GV) Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Genomic Vision (GV) market and the growth estimates for the forecasted period.
Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The companys portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dystrophy; and tools for identifying and characterizing rearrangements which affect the BRCA1 and BRCA2 genes. Its diagnostic tests are based on DNA molecular combing technology. Genomics technology finds application in monitoring both spatial and temporal characteristics of DNA replication in a single experiment and identification of structural variations at any position within the genome. It conducts research studies on large genomic rearrangements. Genomic is headquartered in Paris, France.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1833112
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Genomic Vision
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Request For TOC Report @https://www.marketresearchreports.biz/reports/1833112/genomic-vision-gv-product-pipeline-analysis-2018-update-market-research-reports/toc
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Genomic Vision Company Overview 4
Genomic Vision Company Snapshot 4
Genomic Vision Pipeline Products and Ongoing Clinical Trials Overview 4
Genomic Vision Pipeline Analysis Overview 7
Genomic Vision - Key Facts 7
Genomic Vision - Major Products and Services 8
Genomic Vision Pipeline Products by Development Stage 9
Genomic Vision Ongoing Clinical Trials by Trial Status 11
Genomic Vision Pipeline Products Overview 13
BRCACombing Test 13
BRCACombing Test Product Overview 13
DNA Combing Based Test - Neurological Disorder 14
DNA Combing Based Test - Neurological Disorder Product Overview 14
FiberVision Automated Scanner 15
FiberVision Automated Scanner Product Overview 15
High-Throughput Scanner 16
High-Throughput Scanner Product Overview 16
HPV Combing Test 17
HPV Combing Test Product Overview 17
HPV Combing Test Clinical Trial 18
Lynch Syndrome Test 19
Lynch Syndrome Test Product Overview 19
Telomere Length Assay 20
Telomere Length Assay Product Overview 20
Genomic Vision - Key Competitors 21
Genomic Vision - Key Employees 22
Genomic Vision - Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Genomic Vision, Recent Developments 24
Apr 24, 2018: Genomic Vision Invited to Present FiberVision Platform at the NIST-FDA Genome Editing Workshop in Gaithersburg (Maryland) 24
Jan 17, 2018: Genomic Vision: 2017Annual Revenue from Sales: +36% to 2.1 Million 24
Oct 24, 2017: Genomic Vision: Revenue from Sales for the First 9 Months of 2017 up 103% to 1.3 Million 25
Oct 18, 2017: Genomic Vision: Report of the LSR R&D Day 26
Oct 11, 2017: Genomic Vision Presented the Interim Results of Its Clinical Trial in Cervical Cancer Screening at the Eurogin Annual Congress 26
Sep 11, 2017: Genomic Vision: High Attendance at the 1st US Satellite Symposium on Molecular Combing 27
Jul 27, 2017: Genomic Vision: Molecular Combing Featured in an Oral Presentation on CRISPR/Cas9 Gene Editing at the 3rd CSHL Meeting in New York 27
Jul 25, 2017: Genomic Vision: First half 2017 results 28
Jul 12, 2017: Genomic Vision: The Cologne Center for Genetics, a Major European Core Facility in Genetic Analysis, Adopts the Molecular Combing Technology 29
Jun 19, 2017: Genomic Vision Inks Chinese Distribution Deal with APG Bio 30
Appendix 31
Methodology 31
About GlobalData 33
Contact Us 33
Disclaimer 34
Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The companys portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dystrophy; and tools for identifying and characterizing rearrangements which affect the BRCA1 and BRCA2 genes. Its diagnostic tests are based on DNA molecular combing technology. Genomics technology finds application in monitoring both spatial and temporal characteristics of DNA replication in a single experiment and identification of structural variations at any position within the genome. It conducts research studies on large genomic rearrangements. Genomic is headquartered in Paris, France.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1833112
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Genomic Vision
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Request For TOC Report @https://www.marketresearchreports.biz/reports/1833112/genomic-vision-gv-product-pipeline-analysis-2018-update-market-research-reports/toc
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Genomic Vision Company Overview 4
Genomic Vision Company Snapshot 4
Genomic Vision Pipeline Products and Ongoing Clinical Trials Overview 4
Genomic Vision Pipeline Analysis Overview 7
Genomic Vision - Key Facts 7
Genomic Vision - Major Products and Services 8
Genomic Vision Pipeline Products by Development Stage 9
Genomic Vision Ongoing Clinical Trials by Trial Status 11
Genomic Vision Pipeline Products Overview 13
BRCACombing Test 13
BRCACombing Test Product Overview 13
DNA Combing Based Test - Neurological Disorder 14
DNA Combing Based Test - Neurological Disorder Product Overview 14
FiberVision Automated Scanner 15
FiberVision Automated Scanner Product Overview 15
High-Throughput Scanner 16
High-Throughput Scanner Product Overview 16
HPV Combing Test 17
HPV Combing Test Product Overview 17
HPV Combing Test Clinical Trial 18
Lynch Syndrome Test 19
Lynch Syndrome Test Product Overview 19
Telomere Length Assay 20
Telomere Length Assay Product Overview 20
Genomic Vision - Key Competitors 21
Genomic Vision - Key Employees 22
Genomic Vision - Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Genomic Vision, Recent Developments 24
Apr 24, 2018: Genomic Vision Invited to Present FiberVision Platform at the NIST-FDA Genome Editing Workshop in Gaithersburg (Maryland) 24
Jan 17, 2018: Genomic Vision: 2017Annual Revenue from Sales: +36% to 2.1 Million 24
Oct 24, 2017: Genomic Vision: Revenue from Sales for the First 9 Months of 2017 up 103% to 1.3 Million 25
Oct 18, 2017: Genomic Vision: Report of the LSR R&D Day 26
Oct 11, 2017: Genomic Vision Presented the Interim Results of Its Clinical Trial in Cervical Cancer Screening at the Eurogin Annual Congress 26
Sep 11, 2017: Genomic Vision: High Attendance at the 1st US Satellite Symposium on Molecular Combing 27
Jul 27, 2017: Genomic Vision: Molecular Combing Featured in an Oral Presentation on CRISPR/Cas9 Gene Editing at the 3rd CSHL Meeting in New York 27
Jul 25, 2017: Genomic Vision: First half 2017 results 28
Jul 12, 2017: Genomic Vision: The Cologne Center for Genetics, a Major European Core Facility in Genetic Analysis, Adopts the Molecular Combing Technology 29
Jun 19, 2017: Genomic Vision Inks Chinese Distribution Deal with APG Bio 30
Appendix 31
Methodology 31
About GlobalData 33
Contact Us 33
Disclaimer 34
No comments:
Post a Comment